We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+2.2%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$120M
AUM Growth
+$3.1M
Cap. Flow
+$30.4M
Cap. Flow %
25.24%
Top 10 Hldgs %
19.44%
Holding
209
New
93
Increased
10
Reduced
42
Closed
64

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$3.43M
2
JPM icon
JPMorgan Chase
JPM
+$2.49M
3
V icon
Visa
V
+$2.46M
4
PFE icon
Pfizer
PFE
+$2.46M
5
ADI icon
Analog Devices
ADI
+$1.93M

Top Sells

Rank Stock Value
1
RVTY icon
Revvity
RVTY
+$1.28M
2
LYB icon
LyondellBasell Industries
LYB
+$1.25M
3
FAST icon
Fastenal
FAST
+$1.23M
4
QCOM icon
Qualcomm
QCOM
+$1.21M
5
OXY icon
Occidental Petroleum
OXY
+$1.19M

Sector Composition

Rank Sector Weight
1 Technology 19.77%
2 Financials 18.53%
3 Energy 14.69%
4 Industrials 14.26%
5 Healthcare 13.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
1
ExxonMobil
XOM
$643B
$3.28M 2.72%
+37,550
New +$3.43M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$2.89M 2.4%
97,800
+61,699
+171% +$24.5M
ADI icon
3
Analog Devices
ADI
$176B
$2.85M 2.37%
20,443
+12,191
+148% +$1.93M
CVX icon
4
Chevron
CVX
$385B
$2.38M 1.98%
16,600
+8,197
+98% +$1.25M
JPM icon
5
JPMorgan Chase
JPM
$937B
$2.27M 1.88%
+21,677
New +$2.49M
PFE icon
6
Pfizer
PFE
$143B
$2.21M 1.84%
+50,583
New +$2.46M
V icon
7
Visa
V
$683B
$2.15M 1.79%
+12,105
New +$2.46M
IWM icon
8
PUT
iShares Russell 2000 ETF
IWM
$81.5B
$2M 1.66%
283,500
-1,500
-0.5% -$274K
AAPL icon
9
Apple
AAPL
$4.43T
$1.86M 1.54%
13,440
+4,576
+52% +$718K
UNP icon
10
Union Pacific
UNP
$173B
$1.5M 1.25%
7,726
+5,622
+267% +$1.24M
SCHW
11
Charles Schwab
SCHW
$184B
$1.43M 1.18%
+19,828
New +$1.38M
CVS icon
12
CVS Health
CVS
$134B
$1.41M 1.17%
+14,800
New +$1.46M
MET icon
13
MetLife
MET
$62B
$1.4M 1.17%
23,083
+19,859
+616% +$1.27M
WMT icon
14
Walmart Inc
WMT
$881B
$1.38M 1.15%
+32,013
New +$1.4M
EOG icon
15
EOG Resources
EOG
$77.6B
$1.32M 1.1%
+11,826
New +$1.33M
COP icon
16
ConocoPhillips
COP
$145B
$1.32M 1.09%
+12,862
New +$1.28M
MRK icon
17
Merck
MRK
$316B
$1.29M 1.07%
15,020
+12,787
+573% +$1.14M
TXN icon
18
Texas Instruments
TXN
$246B
$1.26M 1.04%
+8,126
New +$1.36M
DE icon
19
Deere & Co
DE
$163B
$1.24M 1.03%
+3,710
New +$1.27M
ABBV icon
20
AbbVie
ABBV
$433B
$1.24M 1.03%
+9,208
New +$1.32M
NEE icon
21
NextEra Energy
NEE
$181B
$1.21M 1%
+15,382
New +$1.3M
KO icon
22
Coca-Cola
KO
$374B
$1.2M 1%
+21,491
New +$1.34M
ELV icon
23
Elevance Health
ELV
$83B
$1.18M 0.98%
+2,602
New +$1.25M
ACN icon
24
Accenture
ACN
$101B
$1.18M 0.98%
+4,579
New +$1.32M
UNH icon
25
UnitedHealth
UNH
$377B
$1.18M 0.98%
+2,331
New +$1.23M
1
2 3 4 5

Similar funds

CAWM
Capital A Wealth Management New Castle, Pennsylvania $8.94M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
PC
Prysm Capital Princeton, New Jersey $10.6M AUM 2.38% 1-Year Est. Return
CP
Castalian Partners Excelsior, Minnesota $7.36M AUM
AVM
Altos Ventures Management Burlingame, California $11.7M AUM 182.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return
BPWM
Black Point Wealth Management Naples, Florida $3.5M AUM 16.42% 1-Year Est. Return

Alpha DNA Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, Alpha DNA Investment Management held 209 positions worth $120M, up 2.6% from $117M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Alpha DNA Investment Management deployed $30.4M of net new capital in Q3 2022, opening 93 new positions and adding to 10 existing holdings. Its largest new stake was ExxonMobil: 37,550 shares worth $3.28M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 Growth ETF, an estimated $988K trimmed.

  • Alpha DNA Investment Management's largest Q3 2022 buy was ExxonMobil: 37,550 shares worth $3.28M.
  • Alpha DNA Investment Management added most to Analog Devices in Q3 2022, an estimated $1.93M increase.
  • Alpha DNA Investment Management's biggest Q3 2022 reduction was State Street SPDR Portfolio S&P 500 Growth ETF, cutting an estimated $988K.
  • Alpha DNA Investment Management fully exited Revvity in Q3 2022, selling an estimated $1.28M.
  • Alpha DNA Investment Management's ten largest holdings make up 19% of its $120M portfolio in Q3 2022.
  • Alpha DNA Investment Management opened 93 new positions and closed 64 in Q3 2022.
  • Alpha DNA Investment Management's portfolio value rose 2.6% quarter-over-quarter to $120M.

Based on Alpha DNA Investment Management's 13F filing for Q3 2022, filed 15 Nov 2022.